Stoke Therapeutics, Inc. Form 8-K Summary
Business Context and Reporting Period
This Current Report on Form 8-K covers the 2026 Annual Meeting of Stockholders held by Stoke Therapeutics, Inc. on June 3, 2026. The filing details the results of three proposals submitted to security holders for a vote.
Key Financial Metrics
The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. This report focuses exclusively on corporate governance voting outcomes.
Material Changes and Voting Results
The following proposals were adopted at the Annual Meeting:
- Election of Directors: Three Class I directors were elected to three-year terms expiring in 2029:
- G. Clare Kahn, Ph.D.: 49,722,339 shares For; 308,644 shares Withheld.
- Adrian Krainer, Ph.D.: 36,531,612 shares For; 13,499,371 shares Withheld.
- Julie Anne Smith: 43,500,649 shares For; 6,530,334 shares Withheld.
- Ratification of Auditors: Ernst & Young LLP was ratified as the independent registered public accounting firm for the fiscal year ending December 31, 2026.
- 55,121,163 shares For; 2,036 shares Against; 51,714 shares Withheld/Abstaining.
- Executive Compensation Advisory Vote: The compensation of named executive officers was approved on a non-binding advisory basis.
- 36,436,275 shares For; 13,565,293 shares Against; 29,415 shares Withheld/Abstaining.
Guidance, Outlook, and Risks
The filing text does not provide a clear value for guidance, outlook, management commentary, risks, contingencies, or unusual items.
Key Facts for Investor Verification
- Verify the total number of shares outstanding and voting power to contextualize the "Shares Withheld" and "Against" votes, particularly for the director election of Adrian Krainer, Ph.D., which saw significant withholding.
- Confirm the specific compensation details referenced in the proxy statement filed on April 22, 2026, given the substantial number of shares voted against the executive compensation proposal.
- Review the full proxy statement for details on the qualifications and backgrounds of the newly elected directors.